Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Albert Jang, MD, Hussein Hamad, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134801

Published: 2020

Journal Articles

Higher Body Mass Index Is Associated with Differential Mutagenic Dependency in Acute Myeloid Leukemia

Shruti N. Shah, BS, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 38–40.

https://doi.org/10.1182/blood-2020-138564

Published: 2020

Journal Articles

Serum Lipidome and Glucose Metabolism Uncover Vulnerabilities in Myelodysplasia and Secondary Acute Myelogenous Leukemia

Samer Al Hadidi, MD MSc, FACP, Rafee Talukder, MD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-143332

Published: 2020

Journal Articles

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

Jesus Romero, Jorge Mazzini, MD, Sarvari Venkata Yellapragada, MD, Iberia R. Sosa, MD PhD, Gustavo A. Rivero, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141466

Published: 2020

Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 1438.

https://doi.org/10.1182/blood-2019-131581

Published: 2019

Journal Articles

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Joshua P Muniz, MD, Sarvari Venkata Yellapragada, MD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 5420.

https://doi.org/10.1182/blood-2019-131458

Published: 2019

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

Predictors of Survival in Myelodysplastic Patients with Cardiovascular Disease

Gustavo A. Rivero, MD, Vera Schroeder, Sandra Carias, Rafee Talukder, MD, Pedro Emilio Alcedo, MD, Anna Frolov, M.S., M.A

Blood (2018) 132 (Supplement 1): 4386.

https://doi.org/10.1182/blood-2018-99-120267

Published: 2018

Journal Articles

Excess in Atherosclerotic and Inflammametabolic Diseases Are Differentially Expressed in Myelodysplasia and Are Highly Dependent on Age, R-IPSS and Ethnicity

Gustavo A. Rivero, MD, Elias Perli, Stephanie Moreno, Jason L Salemi, PhD, Jason L Salemi, MD

Blood (2018) 132 (Supplement 1): 4855.

https://doi.org/10.1182/blood-2018-99-120303

Published: 2018

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Hussein Hamad, MD, Gustavo A. Rivero, MD

Blood (2018) 132 (Supplement 1): 1464.

https://doi.org/10.1182/blood-2018-99-115830

Published: 2018

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Gabriela Sanchez, MD, Ang Li, MD, Sarvari Venkata Yellapragada, MD, Martha P. Mims, Anna Frolov, Effie Rahman, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5621.

https://doi.org/10.1182/blood.V124.21.5621.5621

Published: 2014

Journal Articles

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

Effie Rahman, Sarvari Venkata Yellapragada, Martha P. Mims, Kirtan Nautiyal, MD, Manuel Molina, MD, Gustavo A. Rivero, MD

Blood (2014) 124 (21): 5628.

https://doi.org/10.1182/blood.V124.21.5628.5628

Published: 2014

Journal Articles

Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides

Ruben Hernandez Perez, Ang Li, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Maria Otazo, Martha Mims, MD, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 1537.

https://doi.org/10.1182/blood.V122.21.1537.1537

Published: 2013

Journal Articles

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

Gustavo A. Rivero, MD, Maria Otazo, Sarvari Venkata Yellapragada, MD, Ang Li, Matthew Zheng, Ruben Hernandez Perez, Martha Mims, MD

Blood (2013) 122 (21): 5233.

https://doi.org/10.1182/blood.V122.21.5233.5233

Published: 2013

Journal Articles

Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome

Maria Otazo, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Ang Li, Ruben Hernandez Perez, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5234.

https://doi.org/10.1182/blood.V122.21.5234.5234

Published: 2013

Journal Articles

Sustained Erythroid Response Associated With Red Cell Transfusion and Progressive Growth Factor Independence Is Feasible With Adjuvant Sertraline In Low-Risk Myelodysplastic Syndrome (LR-MDS)

Rui Li, MD, PhD, Matthew Zheng, Sarvari Venkata Yellapragada, MD, Ruben Hernandez Perez, Martha Mims, MD, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5235.

https://doi.org/10.1182/blood.V122.21.5235.5235

Published: 2013

Journal Articles

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

Matthew Zheng, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5330.

https://doi.org/10.1182/blood.V122.21.5330.5330

Published: 2013

Journal Articles

Acute Differentiation Syndrome Is a Biological Consequence Of Treatment With Azanucleoside In Isocitrate Dehydrogenase-1 ( IDH-1 ) and SFR2 mutated Myelodysplasia Derived Acute Myelogenous Leukemia

Gustavo A. Rivero, MD, Dangayach Priti, MD, Jun Zhang, MD, Marylin Li, MD

Blood (2013) 122 (21): 4982.

https://doi.org/10.1182/blood.V122.21.4982.4982

Published: 2013

NARROW

Weight Loss Predicts Inferior Outcome in Polycythemia Vera Patients

Higher Body Mass Index Is Associated with Differential Mutagenic Dependency in Acute Myeloid Leukemia

Serum Lipidome and Glucose Metabolism Uncover Vulnerabilities in Myelodysplasia and Secondary Acute Myelogenous Leukemia

Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Predictors of Survival in Myelodysplastic Patients with Cardiovascular Disease

Excess in Atherosclerotic and Inflammametabolic Diseases Are Differentially Expressed in Myelodysplasia and Are Highly Dependent on Age, R-IPSS and Ethnicity

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Survival Improvement in Myelodysplastic Syndrome with Refractory Anemia after Treatment with Selective-Serotonin-Reuptake-Inhibitors

Cigarette Smoking Is Associated with Adverse Outcome in Low Risk MDS Patients

Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides

Time Dependent Platelet Attrition Identifies Biological Subgroup In Intermediate But Not Low-Risk Myelodysplastic Syndrome (MDS) Revised-IPSS (R-IPSS) Exhibiting Distinct Overall Survival

Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome

Sustained Erythroid Response Associated With Red Cell Transfusion and Progressive Growth Factor Independence Is Feasible With Adjuvant Sertraline In Low-Risk Myelodysplastic Syndrome (LR-MDS)

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

Acute Differentiation Syndrome Is a Biological Consequence Of Treatment With Azanucleoside In Isocitrate Dehydrogenase-1 ( IDH-1 ) and SFR2 mutated Myelodysplasia Derived Acute Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only